Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination therapy consisting of chloroquine (an antimalarial drug) and glucocorticoids (synthetic corticosteroids). This combination leverages complementary mechanisms to enhance anti-inflammatory effects in various inflammatory and autoimmune conditions. Chloroquine works by inhibiting lysosomal function, interfering with antigen presentation, and reducing pro-inflammatory cytokine production. Glucocorticoids, such as dexamethasone, are potent anti-inflammatory agents that act by regulating gene expression to suppress inflammation. Research has shown that chloroquine can potentiate the effects of glucocorticoids by promoting the transrepression of proinflammatory cytokines by the glucocorticoid receptor (GR).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chloroquine + glucocorticoids.